Cannabinoids in treatment of obstructive sleep apnea syndrome

Introduction and objective Obstructive sleep apnea syndrome (OSAS) is becoming increasingly more prevalent in the general population. Its negative impact on the cardiovascular system and patients’ non-compliance to validated treatment options is a stimulus for research on novel OSAS therapies, inclu...

Full description

Bibliographic Details
Main Authors: Paulina Maria Szot, Antoni Krzeski
Format: Article
Language:English
Published: Institute of Rural Health 2022-06-01
Series:Medycyna Ogólna i Nauki o Zdrowiu
Subjects:
Online Access:https://www.monz.pl/Kannabinoidy-w-leczeniu-zespolu-obturacyjnych-bezdechow-podczas-snu,149729,0,2.html